Skip to main navigation Skip to search Skip to main content

Renal angiomyolipoma based on new classification: How to differentiate it from renal cell carcinoma

Research output: Contribution to journalArticlepeer-review

Abstract

OBJECTIVE. The purpose of this article is to describe useful imaging features for differentiating angiomyolipoma (AML) subtypes from renal cell carcinoma subtypes. CONCLUSION. A newer radiologic classification of renal AML consists of fat-rich AML (≤ –10 HU), fat-poor AML (> –10 HU; tumor-to-spleen ratio < 0.71; signal intensity index, > 16.5%), and fat-invisible AML (> –10 HU; tumor-to-spleen ratio, > 0.71; signal intensity index, < 16.5%). Each subtype must be differentiated from the renal cell carcinoma subtype because of overlapping imaging features.

Original languageEnglish
Pages (from-to)582-588
Number of pages7
JournalAmerican Journal of Roentgenology
Volume212
Issue number3
DOIs
StatePublished - Mar 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Angiomyolipoma
  • Kidney
  • MDCT
  • MRI
  • Renal cell carcinoma

Fingerprint

Dive into the research topics of 'Renal angiomyolipoma based on new classification: How to differentiate it from renal cell carcinoma'. Together they form a unique fingerprint.

Cite this